As of January 22, 2025, Sight Sciences (SGHT) has a market cap of $0.15 billion USD. According to our data, Sight Sciences is ranked No.7396 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.15 B |
-20.88%
|
Dec 31, 2024 | $0.18 B |
-29.46%
|
Dec 29, 2023 | $0.26 B |
-57.74%
|
Dec 30, 2022 | $0.62 B |
-30.51%
|
Dec 31, 2021 | $0.89 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Alcon
ALC
|
$43.91 B |
-0.001 M
|
Switzerland
|
Glaukos
GKOS
|
$8.83 B |
0.000 M
|
USA
|
Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Santen Pharmaceutical
4536.T
|
$3.40 B |
-0.000 M
|
Japan
|
STAAR Surgical
STAA
|
$1.14 B |
0.000 M
|
USA
|
Ocular Therapeutix
OCUL
|
$1.26 B |
-0.000 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Medtronic
MDT
|
$112.64 B |
0.001 M
|
Ireland
|
Cooper Companies
COO
|
$19.00 B |
-0.001 M
|
USA
|
Market Cap | = | SGHT Stock Price | * | SGHT Shares Outstanding |
= | $2.88 | * | 50.40 M | |
= | $0.15 B |